RxDoctor Payments Data

Patrick Dougherty, DPM

Primary Podiatric Medicine · Raleigh, NCNPI 1386616415

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Convatec Inc. at 30.5% of the total.

$2,339in general payments, 2019–2025

Across 65 payments — averaging $35.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$714
  • Amgen$365
  • Smith+Nephew$218
  • AbbVie$216
  • Integra Lifesciences Corporation$126
  • Paratek Pharmaceuticals, Inc.$107
  • plus $593 from 15 others

What the payments were for

  • Food & beverage$2,339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,339 in reported general payments places this provider in the 65th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$187,244
Medicare patients
585
Services billed
2,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl669$5,877
Ketoconazole135$3,685
Gabapentin165$1,605
Nystatin55$693
Cephalexin59$497
Meloxicam119$402
Pregabalin41$356
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$265
Allopurinol16$219
Diclofenac Sodium27$210
Methylprednisolone22$140

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →